Published in Aliment Pharmacol Ther on February 01, 1997
Sleep disturbance influences gastrointestinal symptoms in women with irritable bowel syndrome. Dig Dis Sci (2000) 1.50
Treatment of irritable bowel syndrome: a review of randomised controlled trials. Gut (2001) 1.43
The Differences in Prevalence and Sociodemographic Characteristics of Irritable Bowel Syndrome According to Rome II and Rome III. J Neurogastroenterol Motil (2010) 1.24
A cognitive-behavioral treatment for irritable bowel syndrome using interoceptive exposure to visceral sensations. Behav Res Ther (2011) 1.18
Meta-analysis: do irritable bowel syndrome symptoms vary between men and women? Aliment Pharmacol Ther (2010) 1.14
Brain-Gut Interactions in IBS. Front Pharmacol (2012) 1.10
Autonomic nervous system function in women with irritable bowel syndrome. Dig Dis Sci (2001) 1.08
Serotonin receptor modulators in the treatment of irritable bowel syndrome. Ther Clin Risk Manag (2008) 1.00
Estimating the burden of irritable bowel syndrome: analysis of a nationwide korean database. J Neurogastroenterol Motil (2014) 0.96
Somatic complaints in childhood functional abdominal pain are associated with functional gastrointestinal disorders in adolescence and adulthood. J Pediatr Gastroenterol Nutr (2011) 0.96
Abnormalities of left colonic motility in ambulant nonconstipated patients with irritable bowel syndrome. Dig Dis Sci (2003) 0.93
Prevalence and factors associated with irritable bowel syndrome among medical students of Karachi, Pakistan: a cross-sectional study. BMC Res Notes (2012) 0.92
Personality factors and profiles in variants of irritable bowel syndrome. World J Gastroenterol (2007) 0.90
Memory in the enteric nervous system. Gut (2000) 0.89
The effect of tegaserod on symptoms and quality of life in korean women with irritable bowel syndrome with constipation. J Neurogastroenterol Motil (2010) 0.89
Five personality dimensions in patients with irritable bowel syndrome. Neuropsychiatr Dis Treat (2008) 0.88
New treatments for irritable bowel syndrome in women. Womens Health (Lond Engl) (2008) 0.88
IBS--review and what's new. MedGenMed (2006) 0.87
Prevalence, impact and attitudes toward lower gastrointestinal dysmotility and sensory symptoms, and their treatment in Canada: A descriptive study. Can J Gastroenterol (2007) 0.87
Meal induced rectosigmoid tone modification: a low caloric meal accurately separates functional and organic gastrointestinal disease patients. Gut (2006) 0.84
Central modulation of rectal distension-induced blood pressure changes by alosetron, a 5-HT3 receptor antagonist. Dig Dis Sci (1999) 0.82
Neuroendocrine markers and psychological features in patients with irritable bowel syndrome. Int J Colorectal Dis (2013) 0.82
Irritable bowel syndrome and gastroesophageal reflux disease in primary care: is there a link? Dig Dis Sci (2008) 0.81
Resource utilization associated with irritable bowel syndrome in the United States 1987-1997. Dig Dis Sci (2002) 0.81
Change in functional bowel symptoms after prostatectomy: a case-control study. J Res Med Sci (2011) 0.80
Celiac disease: Serologic prevalence in patients with irritable bowel syndrome. J Res Med Sci (2012) 0.79
Physician perception of IBS management in women and men. Dig Dis Sci (2002) 0.78
Irritable bowel syndrome: a review article. Middle East J Dig Dis (2010) 0.78
Partially hydrolyzed guar gum in the treatment of irritable bowel syndrome with constipation: effects of gender, age, and body mass index. Saudi J Gastroenterol (2015) 0.78
Irritable bowel syndrome: diagnostic approaches in clinical practice. Clin Exp Gastroenterol (2010) 0.77
Could gastrointestinal disorders differ in two close but divergent social environments? Int J Health Geogr (2012) 0.76
Inhibition of gastric secretion relieves diarrhea and postprandial urgency associated with irritable bowel syndrome or functional diarrhea. Dig Dis Sci (1999) 0.76
Factors associated with irritable bowel syndrome symptoms in hemodialysis patients. World J Gastroenterol (2011) 0.75
The mind-body connection in irritable bowel syndrome: A randomised controlled trial of hypnotherapy as a treatment. Health Psychol Open (2015) 0.75
General practitioners believe that hypnotherapy could be a useful treatment for irritable bowel syndrome in primary care. BMC Fam Pract (2004) 0.75
The kappa opioid receptor is associated with the perception of visceral pain. Gut (1998) 0.75
Economic burden of irritable bowel syndrome in China. World J Gastroenterol (2016) 0.75
Development of colorectal sensitization is associated with increased eosinophils and mast cells in dextran sulfate sodium-treated rats. Dig Dis Sci (2004) 0.75
Biosynthesis and processing of fibronectin in NIL.8 hamster cells. J Biol Chem (1979) 1.66
Modulation of gastric sensory and motor functions by nitrergic and alpha2-adrenergic agents in humans. Gastroenterology (1999) 1.42
Surgical outcome after incomplete endoscopic submucosal dissection of gastric cancer. Br J Surg (2010) 1.02
Toward office-based measurement of gastric emptying in symptomatic diabetics using [13C]octanoic acid breath test. Am J Gastroenterol (2000) 1.02
Review article: colonic sensorimotor physiology in health, and its alteration in constipation and diarrhoeal disorders. Aliment Pharmacol Ther (1998) 1.00
Gastric GIST: a single institutional retrospective experience with surgical treatment for primary disease. Eur J Surg Oncol (2007) 0.99
The relationship between plasma leptin and nutritional status in chronic hemodialysis patients. J Korean Med Sci (1999) 0.83
Alpha-lipoic acid inhibits endoplasmic reticulum stress-induced cell death through PI3K/Akt signaling pathway in FRTL5 thyroid cells. Horm Metab Res (2011) 0.79
Esophagomediastinal fistula and esophageal stricture as a complication of esophageal candidiasis: a case report. Gastrointest Endosc (2000) 0.78
A double-walled hexagonal supermolecule assembled by guest binding. J Am Chem Soc (2001) 0.78
Effects of all-trans retinoic acid on sodium/iodide symporter and CCAAT/enhancer-binding protein-homologous protein under condition of endoplasmic reticulum stress in FRTL5 thyroid cells. Horm Metab Res (2011) 0.78
Effect of rebamipide in treatment of Helicobacter pylori-associated duodenal ulcer: attenuation of chemokine expression and nitrosative damage. Dig Dis Sci (2002) 0.77
Akt inhibition enhances the cytotoxic effect of apigenin in combination with PLX4032 in anaplastic thyroid carcinoma cells harboring BRAFV600E. J Endocrinol Invest (2013) 0.77
Inhibition of p21 and Akt potentiates SU6656-induced caspase-independent cell death in FRO anaplastic thyroid carcinoma cells. Horm Metab Res (2013) 0.77
Relationship of sodium/iodide symporter expression with I131 whole body scan uptake between primary and metastatic lymph node papillary thyroid carcinomas. J Endocrinol Invest (2007) 0.76
CCAAT/Enhancer-binding protein-homologous protein sensitizes to SU5416 by modulating p21 and PI3K/Akt signal pathway in FRO anaplastic thyroid carcinoma cells. Horm Metab Res (2012) 0.76
Surgery in the aged in Korea. Arch Surg (1998) 0.76
Analyses of RBC insulin receptor bindings in chronic liver disease. Korean J Intern Med (1986) 0.75